Here are five highlights:
1. Dr. Mobbs implanted the disc at Prince of Wales Private Hospital on April 28.
2. The patient had a degenerative cervical disc at level C6-C7.
3. The AxioMed viscoelastic disc is designed to restore disc height, lordosis, stability and motion of the spine.
4. Australia’s Therapeutic Goods Administration approved the company’s viscoelastic cervical and lumbar Freedom total disc replacement devices in 2016.
5. KICVentures acquired AxioMed in 2014, but AxioMed still owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.
More articles on devices:
Stryker releases video series featuring Jerome Bettis, Fred Funk
5 top global bone cement market players
North American artificial disc replacement market to double by 2023, hitting $614.5M — 7 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
